LendingTree Inc
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
TREE$35.35-3.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| (in thousands) | |||
| Cash flows from operating activities attributable to continuing operations: | |||
| Net (loss) income and comprehensive (loss) income | $(122,404) | $(187,952) | $69,115 |
| Less: Loss from discontinued operations, net of tax | — | — | 4,023 |
| (Loss) income from continuing operations | (122,404) | (187,952) | 73,138 |
| Adjustments to reconcile income from continuing operations to net cash provided by operating activities attributable to continuing operations: | |||
| Loss on impairments and disposal of assets | 5,437 | 6,590 | 3,465 |
| Amortization of intangibles | 7,694 | 25,306 | 42,738 |
| Depreciation | 19,070 | 20,095 | 17,910 |
| Non-cash compensation expense | 39,682 | 59,624 | 68,555 |
| Deferred income taxes | (4,692) | 132,666 | 10,908 |
| Change in fair value of contingent consideration | — | — | (8,249) |
| Bad debt expense | 1,752 | 4,101 | 2,472 |
| Amortization of debt issuance costs | 3,137 | 6,432 | 5,992 |
| Write-off of previously-capitalized debt issuance costs | — | — | 1,066 |
| Amortization of debt discount | — | 1,475 | 30,695 |
| Reduction in carrying amount of ROU asset, offset by change in operating lease liabilities | (4,404) | (1,547) | 12,807 |
| Gain on settlement of convertible debt | (48,562) | — | — |
| Loss (gain) on investments | 114,504 | — | (123,272) |
| Loss on impairment of goodwill | 38,600 | — | — |
| Changes in current assets and liabilities: | |||
| Accounts receivable | 27,706 | 9,143 | (10,289) |
| Prepaid and other current assets | (2,977) | (4,313) | (4,902) |
| Accounts payable, accrued expenses and other current liabilities | (5,541) | (28,418) | (1,537) |
| Income taxes receivable | (140) | 214 | 10,680 |
| Other, net | (1,291) | (449) | (921) |
| Net cash provided by operating activities attributable to continuing operations | 67,571 | 42,967 | 131,256 |
| Cash flows from investing activities attributable to continuing operations: | |||
| Capital expenditures | (12,528) | (11,443) | (35,065) |
| Purchase of equity investment | — | (16,440) | (1,180) |
| Proceeds from the sale of equity investment | — | — | 46,312 |
| Other investing activities | 50 | 7 | — |
| Net cash (used in) provided by investing activities attributable to continuing operations | (12,478) | (27,876) | 10,067 |
| Cash flows from financing activities attributable to continuing operations: | |||
| Payments related to net-share settlement of stock-based compensation, net of proceeds from exercise of stock options | (1,088) | (3,411) | (14,423) |
| Purchase of treasury stock | — | (43,009) | (40,008) |
| Proceeds from term loan | — | 250,000 | — |
| Repayment of term loan | (1,875) | (1,250) | — |
| Repurchases of 0.50% Convertible Senior Notes | (237,464) | — | — |
| Repayment of 0.625% Convertible Senior Notes | — | (169,659) | — |
| Payment of debt issuance costs | (1,580) | (135) | (6,385) |
| Payment of original issue discount on term loan | — | — | (2,500) |
| Other financing activities | 1 | — | (31) |
| Net cash (used in) provided by financing activities attributable to continuing operations | (242,006) | 32,536 | (63,347) |
| Total cash (used in) provided by continuing operations | (186,913) | 47,627 | 77,976 |
| Discontinued operations: | |||
| Net cash provided by operating activities attributable to discontinued operations | — | — | 3,317 |
| Total cash provided by discontinued operations | — | — | 3,317 |
| Net (decrease) increase in cash, cash equivalents, restricted cash and restricted cash equivalents | (186,913) | 47,627 | 81,293 |
| Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period | 298,969 | 251,342 | 170,049 |
| Cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period | $112,056 | $298,969 | $251,342 |
| Non-cash investing activities: | |||
| (Decrease) increase in capital expenditures included in accounts payable and accrued expenses | $(377) | $(294) | $(4,793) |
| Supplemental cash flow information: | |||
| Interest paid | $23,685 | $19,017 | $8,912 |
| Income tax payments | 1,283 | 404 | 186 |
| Income tax refunds | 100 | 287 | 10,503 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.